An important trend in global health R&D are a type of public-private partnership called product development partnerships (PDPs). PDPs are a unique, non-profit business model bringing together public, private, academic and philanthropic sectors to develop technologies for global health. PDPs pave the way for new research on diseases that disproportionately affect people in developing countries and accelerate the development of health products for the most vulnerable populations. The goal of PDPs is to develop safe, effective vaccines, drugs and diagnostics and deliver them to the people who need them most as quickly and cheaply as possible.
For a description of the PDPs that Research!America is currently tracking, please see our PDP fact sheet.
Research!America is a member of the Global Health Technologies Coalition which advocates for research and development of tools to prevent, diagnose, and treat global diseases so health solutions are available when we need them.
To learn more...
JUST RELEASED! See our Product Development Partnership Infographic NEW!
Check our this new infographic to learn more about how Product Development Partnerships work and the diversity and range of key players. This infographic features two Research!America partners - Aeras and the Meningitis Vaccine Project. These PDPs serve as clear-cut case studies of why this innovative new business model approach helps to speed up the global health R&D pipeline and save lives faster!
International Partnership for Microbicides
Partnering to Advance Global Health: Advantages of the Product Development Partnership Model
A matchmaker service that saves lives
July 7, 2011
Research!America Director of Global Health, Jennifer Chow, writes about the new PDP model and recent advances in global health research and development.
The Hill's Congress Blog
Saving lives through innovation
June 13, 2011
Citing Research!America's New Jersey poll data, Rep. Albio Sires (D-NJ) discusses the benefits that the 21st Century Global Health Technology Act would have for global health and U.S. innovation.